We are pleased to share that Cognigrape™ has been selected as a finalist at the NutraIngredients Awards, Mind and Mood category. This recognition reflects our commitment to clinically substantiated botanical ingredients that support cognitive performance and mental clarity.
Cognigrape™ is a standardized red grape juice extract (Vitis vinifera L.) developed for brain-health applications. It is characterized by a defined polyphenol profile, including anthocyanins and proanthocyanidins.
Today’s cognitive health market is looking for products that are both science-backed and easy to integrate into everyday life. Cognigrape™ was developed to address this demand with a rare combination of fast-acting and long-term support, delivered at a practical dose and supported by rigorous human evidence.
Cognigrape™ has been clinically evaluated at 250 mg/day in two randomized, double-blind, placebo-controlled human trials in healthy older adults (N=111 and N=96). Across validated cognitive assessments, results support benefits in key cognitive domains relevant to everyday performance, including attention and memory.
What makes the evidence particularly distinctive is the time-course: the more recent trial included an early assessment within 90 minutes of the first intake, followed by additional assessments at 2, 4 and 12 weeks, providing a clear view of how benefits can appear early and continue with ongoing use. In addition, the first clinical study also reported improvements in emotional wellbeing questionnaire outcomes, suggesting that supporting cognitive performance can positively influence how people feel in day-to-day life.
Cognigrape™ is supported by:
- Validated cognitive testing tools used in clinical research to assess multiple domains of cognition
- A low daily dose that supports formulation efficiency
- A powder format suitable for mainstream supplement delivery systems
A reassuring safety profile supported by clinical use and a US self-affirmed GRAS dossier
